| ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
08/06 |
08:00 |
| authID Partners with Art Sales Vault to Bring Biometric Identity Verification to the Art Market |
Globe Newswire |
08/06 |
08:00 |
| Tejon Ranch Company Announces Second Quarter 2026 Financial Results |
Globe Newswire |
08/06 |
08:00 |
| Vortex Energy Receives Final Technical Study Results for the Robinsons River Salt Project |
Globe Newswire |
08/06 |
08:00 |
| ASP Isotopes Inc. Announces that Renergen Limited’s Subsidiary has Entered into a Take-or-Pay Contract for the Supply of Liquified Natural Gas to Be Produced at the Virginia Gas Project in South Africa |
Globe Newswire |
08/06 |
08:00 |
| MIRA Reports Positive 7-Day Dog Study Results for SKNY-1 |
Globe Newswire |
08/06 |
08:00 |
| Ascendis Announces COACH Week 78 Results and Provides Update on Achondroplasia Programs and YUVIWEL® Uptake in the U.S. |
Globe Newswire |
08/06 |
08:00 |
| Genius Group Launch First Phase of $14 Million Genius City Project in Nuanu, Bali |
Globe Newswire |
08/06 |
08:00 |
| EPRI Launches Effort to Reduce Risk in AI Power Sector Deployment |
Globe Newswire |
08/06 |
08:00 |
| VoIP-Pal Granted Leave to File Amended Antitrust Complaint in D.C. Litigation |
Globe Newswire |
08/06 |
08:00 |
| Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update |
Globe Newswire |
08/06 |
08:00 |
| Theriva™ Biologics Announces First Patient Dosed in VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma |
Globe Newswire |
08/06 |
08:00 |
| Proscia Receives New FDA 510(k) Clearance for Concentriq AP-Dx with Predetermined Change Control Plan |
Globe Newswire |
08/06 |
08:00 |
| LaunchDarkly Surpasses $200 Million in ARR as Demand for Runtime Control Accelerates |
Globe Newswire |
08/06 |
08:00 |
| Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results |
Globe Newswire |
08/06 |
08:00 |
| vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
08/06 |
08:00 |
| Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases |
Globe Newswire |
08/06 |
08:00 |
| BLAQclouds, Inc. Announces Major theAlley.io Platform Upgrades and Progress Toward BLAQclouds Property Group and Apollo Direct Market Symbols and Q2 Financials Update |
Globe Newswire |
08/06 |
08:00 |
| Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week |
Globe Newswire |
08/06 |
08:00 |
| X-energy, Centrus Sign HALEU Supply Agreement for Xe-100 Advanced Small Modular Reactor Development |
Globe Newswire |
08/06 |
08:00 |
| MBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights |
Globe Newswire |
08/06 |
08:00 |
| General Fusion to Host Business Update Conference Call on August 18, 2026 |
Globe Newswire |
08/06 |
08:00 |
| Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement |
Globe Newswire |
08/06 |
08:00 |
| Rezolve Ai to Report H1 2026 Results and Host Investor Call on September 1 |
Globe Newswire |
08/06 |
08:00 |
| Merlin Achieves Next Stage in Certification of Its Autonomous Flight Technology |
Globe Newswire |
08/06 |
08:00 |
